News and press releases

New treatment against Duchenne muscular dystrophy

EMA has recommended granting a conditional marketing authorisation in the European Union (EU) for Duvyzat (givinostat) as a treatment for Duchenne muscular dystrophy (DMD) in…

May 12, 2025 - 09:54
 0
New treatment against Duchenne muscular dystrophy
EMA has recommended granting a conditional marketing authorisation in the European Union (EU) for Duvyzat (givinostat) as a treatment for Duchenne muscular dystrophy (DMD) in…
Read More

Tags:

Previous Article

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP...

Next Article

EMA business hours over Easter holiday period

Related Posts

EMA business hours over Easter holiday period

EMA business hours over Easter holiday period

May 12, 2025  0

Measures to minimise risk of suicidal thoughts with finasteride and dutasteride medicines

Measures to minimise risk of suicidal thoughts with fin...

May 8, 2025  0

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 5-8 May 2025

Meeting highlights from the Pharmacovigilance Risk Asse...

May 8, 2025  0